Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Furanica Inc
Profile last edited on: 10/2/2019      CAGE: 7SPF1      UEI: EXSNSDEFJVZ1

Business Identifier: Furan fatty acids (FuFAs): cardiovascular health protection nutraceuticals / pharmaceuticals
Year Founded
2017
First Award
2018
Latest Award
2018
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2731 Lillard Drive
Davis, CA 95618
   N/A
   N/A
   N/A
Location: Single
Congr. District: 04
County: Yolo

Public Profile

Anchored in technology licensed from University of California Davis, Furanica Inc is involved in the development of furan fatty acids (FuFAs) These naturally occurring lipids in fish oils, are being examined as nutraceuticals and pharmaceuticals that could potentially be a factor is protecting cardiovascular health

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$224,944
Phase II Dollars
$0
Total Awarded
$224,944

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2018 1 NIH $224,944
Project Title: Furan Fatty Acids (Fufas) as the Active Components of Fish Oils and Omega-3 Fatty Acid Products
0 1 NIH $299,169
Project Title: Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
0 1 NIH $293,543
Project Title: Structurally engineered N-acyl amino acids for the treatment of NASH

Key People / Management

  Fei Chang

  Francisco Jose Schopfer

Company News

There are no news available.